HC impleads online medicine traders in plea seeking ban on e-pharmacies

Chennai: The Madras High Court Friday allowed firms involved in online sale of medicines to be impleaded in a petition seeking a ban on their business. Justice R Mahadevan, who has granted an interim stay on sale of medicines online by those not having required licence, impleaded the petitioners, including New Delhi-based 1MG Technologies Private Limited, as party to the petition filed by the Tamil Nadu Chemists and Druggists Association (TNCDA).

He impleaded the petitioners after hearing arguments by senior counsels for them and also the TNCDA and adjourned the matter to November 9 for further hearing.

The Judge had on Wednesday granted an interim order restraining online sale of medicines, but clarified Thursday that his order was applicable only to those firms which do not have valid licences.

TNCDA has sought a ban on online sale of medicines contending that purchasing drugs from unlicensed online stores can be risky as they may sell fake, expired, contaminated or unapproved drugs that are dangerous to the health of patients.

A battery of senior lawyers appearing for the impleading petitioners submitted their clients were only intermediaries, providing a platform between the customer and the pharmacies, and not involved in online sale of medicines and drugs of any sort.

E-pharmacy was an initiative to help the caregivers select the most appropriate health care services at the best possible price, the counsels said.

The e-pharmacists have entered into facilitation agreements with various third party pharmacies across the country and they neither stocked medicines nor were having any shop. The orders were placed on the basis of prescription issued by the doctors, they said.

Hence the online firms were not obligated to procure a license under the Drugs and Cosmetics Rules 1955, they reasoned.

Arguing on behalf of the TNCDA, senior counsel A R L Sundaresan submitted that even for exhibition and offer of sale itself the online companies needed licence.

  • Related Posts

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Eli Lilly working on single-dose drug to be administered via IV for long-term gain Mumbai: For millions of heart patients struggling with elevated levels of cholesterol, there is a ray…

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Regeneron Pharmaceuticals, Inc. has announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, a strategic investment that deepens its global operations and scales business functions to advance…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    Gene Therapy for Cholesterol: Initial Test Results Cheer

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    US Biotech Regeneron to launch Global Capability Centre in Hyderabad

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states